Skip to main content
ISPR logo

ISPR · Ispire Technology Inc.

Track ISPR — free
$1.47 -0.02 (-1.34%) At close · Aug 26
Market Cap
$85.53M
Shares
57.40M

Ispire Technology Inc. Earnings Call Transcripts

Quarterly earnings calls for Ispire Technology Inc. (ISPR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2025-12-31
Ispire Technology Inc. (ISPR) Q2 2026 Earnings Call Transcript
Confident tone Age-gating technology and FDA opportunity Malaysia manufacturing facility Cash flow and accounts receivable improvement
Revenue
$20.29M
▼ 51.5% YoY
Diluted EPS
$-0.12
Gross margin
17.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-09-30
Ispire Technology Inc. (ISPR) Q1 2026 Earnings Call Transcript
Positive tone Cost reduction and expense management Strategic shift away from cannabis G-Mesh and ODM nicotine partnerships
Revenue
$30.35M
▼ 22.8% YoY
Diluted EPS
$-0.06
Gross margin
17.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-06-30
Ispire Technology Inc. (ISPR) Q4 2025 Earnings Call Transcript
Positive tone Strategic pivot from cannabis to nicotine IKE Tech PMTA regulatory milestone Malaysia manufacturing expansion
Revenue
$20.14M*
▼ 46.1% YoY
Gross margin
12.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-05-12
Ispire Technology Inc. (ISPR) Q3 2025 Earnings Call Transcript
Positive tone Malaysia Manufacturing Expansion Customer Diversification and Supply Chain IKE Tech PMTA and Age-Gating
Revenue
$26.19M
▼ 12.7% YoY
Diluted EPS
$-0.19
Gross margin
18.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-02-10
Ispire Technology Inc. (ISPR) Q2 2025 Earnings Call Transcript
Confident tone Component PMTA / age-gating opportunity International nicotine expansion Cost-saving initiatives
Revenue
$41.83M
▲ 0.3% YoY
Diluted EPS
$-0.14
Gross margin
18.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-11-12
Ispire Technology Inc. (ISPR) Q1 2025 Earnings Call Transcript
Confident tone Gross Margin and Profitability Improvement Cash Flow and Accounts Receivable I-80 Vape Filling Machine Launch
Revenue
$39.34M
▼ 8.2% YoY
Diluted EPS
$-0.10
Gross margin
19.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-09-26
Ispire Technology Inc. (ISPR) Q4 2024 Earnings Call Transcript
Confident tone Record revenue and margin expansion PMTA application and FDA engagement Strategic partnerships and ODM deal
Revenue
$37.34M*
▲ 14.4% YoY
Gross margin
28.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-05-15
Ispire Technology Inc. (ISPR) Q3 2024 Earnings Call Transcript
Positive tone Revenue growth and financial performance Ispire ONE technology and filling machine delays Berify and Chemular joint venture (age verification)
Revenue
$30.02M
▲ 24.4% YoY
Diluted EPS
$-0.11
Gross margin
20.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-02-20
Ispire Technology Inc. (ISPR) Q2 2024 Earnings Call Transcript
Confident tone Operating expenses, losses, and cash burn Cannabis hardware growth PMTA and U.S. nicotine market opportunity
Revenue
$41.69M
▲ 30.7% YoY
Diluted EPS
$-0.07
Gross margin
15.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-11-14
Ispire Technology Inc. (ISPR) Q1 2024 Earnings Call
Revenue
$42.86M
▲ 59.1% YoY
Diluted EPS
$-0.02
Gross margin
16.0%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-09-19
Ispire Technology Inc. (ISPR) Q4 2023 Earnings Call
Revenue
$32.63M*
Gross margin
19.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–11 of 11 earnings calls
Key facts CIK 1948455 CUSIP 46501C100 13F (30d) 42 filings 42 filers Visit website Investor relations